Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy

Background/Aim. Introducing tyrosine kinase inhibitors (TKIs) has essentially changed curative approach, to be precise, clearly improved treatment efficacy for chronic myeloid leukemia (CML). Thus, the place and usage of allogeneic stem cell transplant (SCT) in CML treatment - as a former "n...

Full description

Bibliographic Details

Published in:	Vojnosanitetski Pregled
Main Authors:	Stamatović Dragana, Balint Bela, Tukić Ljiljana, Elez Marija, Tarabar Olivera, Todorović Milena, Todorić-Živanović Biljana, Ostojić Gordana, Tatomirović Željka, Marjanović Slobodan, Malešević Milomir
Format:	Article
Language:	English
Published:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2012-01-01
Subjects:	leukemia, myelogenous chronic bcr-abl positive stemcells transplantation homologous treatment outcome
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2012/0042-84501201037S.pdf